These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 35693799)

  • 1.
    Booth CE; Powell-Pierce AD; Skare JT; Garcia BL
    Front Immunol; 2022; 13():886733. PubMed ID: 35693799
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Conformational dynamics of complement protease C1r inhibitor proteins from Lyme disease- and relapsing fever-causing spirochetes.
    Roy S; Booth CE; Powell-Pierce AD; Schulz AM; Skare JT; Garcia BL
    J Biol Chem; 2023 Aug; 299(8):104972. PubMed ID: 37380082
    [TBL] [Abstract][Full Text] [Related]  

  • 3. "Conformational dynamics of C1r inhibitor proteins from Lyme disease and relapsing fever spirochetes".
    Roy S; Booth CE; Powell-Pierce AD; Schulz AM; Skare JT; Garcia BL
    bioRxiv; 2023 Mar; ():. PubMed ID: 36909632
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structural determination of the complement inhibitory domain of Borrelia burgdorferi BBK32 provides insight into classical pathway complement evasion by Lyme disease spirochetes.
    Xie J; Zhi H; Garrigues RJ; Keightley A; Garcia BL; Skare JT
    PLoS Pathog; 2019 Mar; 15(3):e1007659. PubMed ID: 30897158
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Borrelia burgdorferi BBK32 Inhibits the Classical Pathway by Blocking Activation of the C1 Complement Complex.
    Garcia BL; Zhi H; Wager B; Höök M; Skare JT
    PLoS Pathog; 2016 Jan; 12(1):e1005404. PubMed ID: 26808924
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Structural Basis for Inhibition of the Complement Initiator Protease C1r by Lyme Disease Spirochetes.
    Garrigues RJ; Powell-Pierce AD; Hammel M; Skare JT; Garcia BL
    J Immunol; 2021 Dec; 207(11):2856-2867. PubMed ID: 34759015
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lipoproteome screening of the Lyme disease agent identifies inhibitors of antibody-mediated complement killing.
    Pereira MJ; Wager B; Garrigues RJ; Gerlach E; Quinn JD; Dowdell AS; Osburne MS; Zückert WR; Kraiczy P; Garcia BL; Leong JM
    Proc Natl Acad Sci U S A; 2022 Mar; 119(13):e2117770119. PubMed ID: 35312359
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multifunctional interaction of CihC/FbpC orthologs of relapsing fever spirochetes with host-derived proteins involved in adhesion, fibrinolysis, and complement evasion.
    Damm AS; Reyer F; Langhoff L; Lin YP; Falcone FH; Kraiczy P
    Front Immunol; 2024; 15():1390468. PubMed ID: 38726006
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The molecular determinants of classical pathway complement inhibition by OspEF-related proteins of Borrelia burgdorferi.
    Thomas S; Schulz AM; Leong JM; Zeczycki TN; Garcia BL
    J Biol Chem; 2024 May; 300(5):107236. PubMed ID: 38552741
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Complement evasion strategies of Borrelia burgdorferi sensu lato.
    Dulipati V; Meri S; Panelius J
    FEBS Lett; 2020 Aug; 594(16):2645-2656. PubMed ID: 32748966
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Complement Binding and Inhibitory Protein CbiA of
    Nguyen NTT; Röttgerding F; Devraj G; Lin YP; Koenigs A; Kraiczy P
    Front Cell Infect Microbiol; 2018; 8():23. PubMed ID: 29456970
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Versatile roles of CspA orthologs in complement inactivation of serum-resistant Lyme disease spirochetes.
    Hammerschmidt C; Koenigs A; Siegel C; Hallström T; Skerka C; Wallich R; Zipfel PF; Kraiczy P
    Infect Immun; 2014 Jan; 82(1):380-92. PubMed ID: 24191298
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Borrelia burgdorferi and Borrelia miyamotoi seroprevalence in California blood donors.
    Brummitt SI; Kjemtrup AM; Harvey DJ; Petersen JM; Sexton C; Replogle A; Packham AE; Bloch EM; Barbour AG; Krause PJ; Green V; Smith WA
    PLoS One; 2020; 15(12):e0243950. PubMed ID: 33370341
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inactivation of the fibronectin-binding adhesin gene bbk32 significantly attenuates the infectivity potential of Borrelia burgdorferi.
    Seshu J; Esteve-Gassent MD; Labandeira-Rey M; Kim JH; Trzeciakowski JP; Höök M; Skare JT
    Mol Microbiol; 2006 Mar; 59(5):1591-601. PubMed ID: 16468997
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Complement Evasion by Lyme Disease Spirochetes.
    Skare JT; Garcia BL
    Trends Microbiol; 2020 Nov; 28(11):889-899. PubMed ID: 32482556
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Outer surface lipoproteins from the Lyme disease spirochete exploit the molecular switch mechanism of the complement protease C1s.
    Garrigues RJ; Thomas S; Leong JM; Garcia BL
    J Biol Chem; 2022 Nov; 298(11):102557. PubMed ID: 36183830
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Borrelia burgdorferi lacking BBK32, a fibronectin-binding protein, retains full pathogenicity.
    Li X; Liu X; Beck DS; Kantor FS; Fikrig E
    Infect Immun; 2006 Jun; 74(6):3305-13. PubMed ID: 16714558
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fibronectin binding protein BBK32 of the Lyme disease spirochete promotes bacterial attachment to glycosaminoglycans.
    Fischer JR; LeBlanc KT; Leong JM
    Infect Immun; 2006 Jan; 74(1):435-41. PubMed ID: 16368999
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Host Immune Evasion by Lyme and Relapsing Fever Borreliae: Findings to Lead Future Studies for
    Stone BL; Brissette CA
    Front Immunol; 2017; 8():12. PubMed ID: 28154563
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structural basis for complement evasion by Lyme disease pathogen Borrelia burgdorferi.
    Bhattacharjee A; Oeemig JS; Kolodziejczyk R; Meri T; Kajander T; Lehtinen MJ; Iwaï H; Jokiranta TS; Goldman A
    J Biol Chem; 2013 Jun; 288(26):18685-95. PubMed ID: 23658013
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.